AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get health and wellness essentials delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Geriatrician Nathaniel Chin argues that repeat cognitive testing can help clinicians compare a person’s performance with their own baseline, as well as with age-based norms. He says trends can add context to a single score, but testing conditions, practice effects and the right interval between assessments matter.

Geriatrician Nathaniel Chin says repeat cognitive testing can help clinicians see whether a person’s thinking abilities are changing over time, a perspective he laid out in a September 29 commentary for Being Patient. He argues that comparing results with a person’s own baseline can add information that a single score against age-based norms cannot provide.

Standard cognitive tests compare a person’s performance with that of a normative group, often people of similar age and, depending on the test, similar education or demographic backgrounds. Chin says this comparison helps clinicians judge whether a score falls within an expected range. It may not reveal whether a score represents a meaningful change for that individual, whose lifelong strengths and weaknesses can differ from the group average.

Chin recommends considering a broad range of abilities, including memory, attention, language, executive function, processing speed and visuospatial skills. A brief memory screen may miss changes in other areas, and patterns across abilities can help clinicians consider different possible causes. He also cautions that a low score alone does not establish decline: some people may have performed similarly throughout adulthood.

Testing results can vary with sleep, anxiety, depression, stress, medication effects, illness or simply having a difficult day, Chin writes. Follow-up months or years later can provide added context. Stable or improved results may shift attention toward possible reversible contributors, while consistent decline across assessments, especially in a recognizable pattern, can raise greater concern about an underlying neurodegenerative process. These are clinical considerations, not a diagnosis based on testing alone.

At a glance
analysisWhen: Published September 29, 2026
The developmentIn a September 29, 2026, Being Patient commentary, physician Nathaniel Chin explains how repeat cognitive testing can help identify changes that a single assessment may not show.

How Trends Add Clinical Context

For people concerned about memory or thinking, one result can be hard to interpret. Comparing later performance with an established baseline may help clinicians distinguish a longstanding pattern from a change, even when a score remains within the range considered normal for a person’s peers. Chin says this is especially relevant for people with high educational or occupational attainment, whose decline may not push a score outside that range.

Repeated, broad assessments may also offer information about the course and pattern of change. Chin says persistent decline across evaluations can prompt greater concern than a single unexpectedly low result. The value is added context for clinical judgment; the commentary does not present repeat testing as a stand-alone way to diagnose Alzheimer’s disease or another condition.

From Screening to Personal Baselines

Chin describes cognitive testing as one part of evaluating concerns about memory or thinking. Normative comparisons help place results alongside those of other people, but they cannot fully answer whether a performance is different from that person’s own earlier abilities. A baseline gives later assessments another point of comparison.

He connects repeat testing with earlier stages of concern, including subjective cognitive decline, when people notice changes despite standard testing that may remain in the expected range, and mild cognitive impairment. The source says Alzheimer’s disease can develop over many years and that subtle changes may precede dementia. The supplied report ends partway through its discussion of these conditions, so it does not provide further detail about their assessment or management.

What Test Results Cannot Settle

The commentary does not set a recommended testing schedule or specify an interval that suits everyone. It says timing matters because people may improve through familiarity with test material, and that alternate versions can help address this effect. How much a score changes and what that change means in a particular case remain matters for clinical interpretation.

The source also does not establish that a particular pattern of results confirms Alzheimer’s disease. Chin says consistent decline can raise concern, while sleep, mood, stress, medication, illness and other circumstances can influence performance. The supplied source excerpt cuts off during its discussion of subjective cognitive decline and mild cognitive impairment, leaving the remainder of that discussion unavailable.

Follow-Up Can Clarify the Pattern

Chin’s account points to follow-up assessment as a way to add context after an initial evaluation, with timing and task selection considered carefully. A clinician can compare results with both normative data and the person’s earlier performance, while taking into account factors that may have affected either session.

The commentary does not announce a new test, study, guideline or scheduled policy change. It offers a physician’s perspective on how repeat assessments may inform evaluation. The next step for any individual depends on their circumstances and clinical assessment; the article does not give a universal timetable.

Key Questions

Why repeat a cognitive test?

Repeat testing can show change over time by letting clinicians compare results with a person’s own earlier performance as well as with normative data, Chin says.

Does one low score mean someone has Alzheimer’s disease?

No conclusion like that follows from the commentary. Chin says a low score may reflect a longstanding pattern or temporary influences; clinicians consider the full assessment and changes across time.

What can affect cognitive test results?

Chin lists poor sleep, anxiety or depression, stress, some medications, illness and having a difficult day as possible influences on performance.

Can scores improve on a repeat test?

Yes. Chin says familiarity with the material can raise scores. He notes that testing intervals matter and that assessments may use alternate versions of tasks.

Which abilities can a broad assessment cover?

Chin names memory, attention, language, executive function, processing speed and visuospatial abilities. A broader assessment may reveal patterns a brief memory screen misses.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
HALLOWEEN

Halloween Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

Not Ready for a Knee Replacement? A Minimally Invasive Procedure May Ease Chronic Pain Without Joint Replacement

A new minimally invasive procedure may help patients with chronic knee pain avoid full joint replacement. Experts discuss its benefits and limitations.

Kodiak Sciences Surges In Global Coverage

Kodiak Sciences’ stock experiences a significant rise as global media mentions increase, indicating heightened investor and public interest.

Inside a Live AI-Driven Business Fighting for Survival — and What It Means for Your Work

A groundbreaking live experiment puts AI models through their paces in running a company, revealing strengths, weaknesses, and lessons vital for AI’s role in health and business.

‘Better Informed Than Any Doctor In The Country’: What We Heard This Week

MedPage Today’s October 4 roundup features comments on AI, Medicare prevention, GLP-1 drugs, tick larvae and other medical topics.